The NuvaRing injury lawyers at The Driscoll Firm, LLC, believe that the more you know about the medications you take and the products you use, the safer you will be.
On this page you will find answers to common questions about NuvaRing contraceptive vaginal ring.
For additional information, please call a member of our NuvaRing litigation team at 314-932-3232 or use this contact form. You will speak with a caring and dedicated professional who understands what you are going through. You will get straight talk – not a legal runaround – at no charge and with no strings attached.
Click on any of the following questions to go directly to the topic:
NuvaRing is a flexible plastic ring about the size of a silver dollar that is manually inserted into the vagina once a month. It is held in place by the vaginal muscles. Over a three-week time period, the ring releases low doses of progestin and estrogen hormones that suppress ovulation to prevent pregnancy.
NuvaRing was approved by the U.S. Food and Drug Administration in 2001. It is the only birth control device of its kind sold in this country and is available only by a doctor’s prescription.
Several different big corporations have had a hand in bringing NuvaRing to the United States market. The device was originally developed by Organon, a Dutch pharmaceutical company. In 2007, Schering-Plough purchased Organon, and in 2009 Schering-Plough merged with Merck & Company.
NuvaRing has proven to be an extremely popular method of birth control. More than 1.5 women worldwide use it – one million of them in the United States. This year approximately five million NuvaRing prescriptions will be written in this country alone.
Sales of NuvaRing bring in hundreds of millions of dollars each year to its manufacturer Merck.
NuvaRing works by releasing a low dosage of the hormones progestin (etonogestral) and estrogen during the three-week period it is inside the vagina. These arethe same hormones found in so-called “third generation” birth control pills.The FDA has found that third generation contraceptives can double a woman’s risk of blood clots as compared with other contraceptives.
NuvaRing releases a continuous dose of hormones into the body, unlike the fluctuating doses that occur with birth control pills. And the hormones are released directly into the bloodstream instead of through the stomach, as with pills.
Yes. If you or a loved one has used NuvaRing and suffered blood clots, heart attack, stroke, pulmonary embolism, deep vein thrombosis, liver disease, gallbladder disease or other complications, you are entitled to a free and confidential consultation with an experienced NuvaRing injury attorney. Call 888-511-0123 or use this contact form. Compensation can include doctor expenses, hospital bills, lost income, and pain and suffering.
No. NuvaRing is not recommended for women:
- With a history of blood clots, heart attack or stroke;
- With breast cancer;
- Who are pregnant or think they might be;
- Who are over 35 and smoke cigarettes;
- Who suffer from migraines.
Like other contraceptives – and most prescription drugs generally – there are some known side effects of NuvaRing use, including:
- Minor bleeding or spotting
- Fluid retention
- Vaginal irritation, infection or secretion
- Weight gain
- Decreased sex drive
- Mild depression
Yes. Approximately 1,000 serious adverse incidents have been reported to the FDA by women using NuvaRing and their doctors. Reported problems include:
- Blood clots
- Deep Vein Thrombosis (DVT)
- Heart attack
- Heart arrhythmia
- Pulmonary embolism
- Liver cancer
- Gallbladder disease
A particularly poignant case was described in an article in Marie Claire magazine, where a 26-year-old woman developed life-threatening blood clots linked to NuvaRing use.
Yes. In May 2012, the British Medical journal published a Danish study of more than 600,000 women ages 15 to 49 who were using hormonal contraceptives including NuvaRing. The researchers found that NuvaRing use increased the risk of thrombosis by 6.5 times compared to women of the same age using some other contraceptive.
In 2012 the FDA released the results of another study that concluded that women who use NuvaRing run a 48 percent higher risk of blood clots.
Cardiovascular side effects enhanced by NuvaRing use included:
- Venous thromboembolic events (VTE);
- Pulmonary embolism (PE);
- Arterial thrombotic events (ATE), including heart attack, acute myocardial infarction, and ischemic stroke.
Yes. CBS News reported that there have been as many as 40 NuvaRing deaths worldwide.
One fatality in New Jersey received widespread publicity. There, a 32 year old mother of two who was using NuvaRing was killed by a sudden blood clot that traveled from her pelvic area to her lungs. She died on the floor of her home with her children and husband watching, according to news reports.
The surviving family members in that case have brought a NuvaRing wrongful death lawsuit seeking compensation for the loss of their loved one.
No, despite public calls by consumer watchdog groups like Public Citizen for immediate removal of NuvaRing from the market.
This does not prevent an injured person from filing NuvaRing lawsuit. A NuvaRing personal injury lawsuit or NuvaRing wrongful death lawsuit can be filed even though the product has not been recalled.
Yes. It is estimated that as many as 1,000 lawsuits have been filed in state and federal courts across the country.
Those lawsuits allege that the big companies that make and sell NuvaRing minimized the risks and misled consumers about NuvaRing’s safety and effectiveness.
No. Lawsuits are being filed separately. A large number of NuvaRing federal lawsuits have been consolidated in a Multidistrict Litigation (MDL) case in Missouri. Another group of lawsuits have been grouped together in New Jersey.
A qualified NuvaRing litigation attorney can help determine the best way for you to proceed with your NuvaRing injury claim.
Contact an attorney who is experienced with drug liability litigation in general and NuvaRing injury lawsuits in particular.
The NuvaRing litigation team at The Driscoll Firm, LLC, is accepting cases of NuvaRing injury and death nationwide. Call 314-932-3232 or use this contact form for a free, confidential case evaluation today.
John J. Driscoll has a proven record of fighting for people and families injured through the use of pharmaceuticals such as NuvaRing. He was the first attorney in the United States to win a financial award for injuries from YAZ birth control pills. He was won thousands of drug injury claims against big companies like Merck.
- FDA – Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints
- Public Citizen
- BMJ: “Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10,” published May 10, 2012 by BMJ.
- Mother Jones
- Public Citizen
- FDA – Combined Hormonal Contraceptives and the Risk of Cardiovasculor Disease Endpoints
- CBS News MoneyWatch
- Marie Claire magazine (26 year old victim)
- National Library of Medicine
- U.S. Centers for Disease Control and Prevention; U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
- U.S. Food and Drug Administration – NuvaRing approval correspondence